NDAORALTABLET
Approved
Jan 2022
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
1
Mechanism of Action
Orexin Receptor Antagonists
Pharmacologic Class:
Orexin Receptor Antagonist
Clinical Trials (1)
A Study to Evaluate the Efficacy and Safety of Daridorexant in Participants With Insomnia Disorder
Started Dec 2024
Loss of Exclusivity
LOE Date
Dec 2, 2034
106 months away
Patent Expiry
Dec 2, 2034
Exclusivity Expiry
Sep 30, 2027